Commonly asked questions about Levitra


Levitra comes third in the list of most popular erectile dysfunction (ED) pills. After Viagra and Cialis, this medicine also enjoys a loyal customer base in the US. For all your queries about Levitra, read on:

What is Levitra?
For those who are suffering from impotence, there is no need to introduce the topic. This male sexual health problem can be very disturbing regardless of the age of the individual who suffers from it. Levitra is a prescription impotence drug manufactured by Bayer and marketed by GlaxoSmithKline.

How is Levitra different from Viagra and Cialis?
Levitra works in the same way as Viagra and Cialis. These drugs belong to a class of medicines known as phosphodiesterase type 5 (PDE-5) inhibitor. Despite this similarity, Levitra is different from the other 2 ED drugs in terms of its effectiveness in treating impotence in men who have other health conditions such as cardiovascular diseases, high blood pressure and high cholesterol. As old men suffer more from these underlying health conditions compared to men below 40, Levitra is usually recommended for erectile dysfunction treatment in old-age.

What is the success rate of Levitra?
The Bayer pill has an impressive success rate as far as impotence treatment is concerned. It is estimated that 9 out of 10 men who take the medicine as prescribed by their doctors get improved erections and also experience enhanced sexual satisfaction.

Can women take Levitra?
No, Levitra is only recommended for men suffering from erectile dysfunction. The US Food and Drug Administration (FDA) has not tested this medicine for female sexual dysfunction (FSD). But some studies have suggested that women who suffer from sexual dysfunction because of their dependence on antidepressants can get help from Levitra. However, the results are not yet conclusive and most importantly, are not verified by the FDA. So if a woman wants to buy Levitra for FSD treatment, she has to do it at her own risk.

Bookmark and Share
  1. No comments yet.
(will not be published)